BGT vs PTX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

36LOW

PTX

PRESCIENT FPO [PTX]

58MEDIUM

Score Breakdown

BGT PTX
Technical
48
83
Catalyst
50
53
Sentiment
50
50
Fundamental
44
53
Momentum
52
75
Risk Gate
27
50

Key Metrics

BGT Metric PTX
$6.6MMarket Cap$78.9M
754KAvg Volume (20d)886K
N/AShort InterestN/A
$0.06152-Week High$0.125
$0.01652-Week Low$0.040
+0.0%Daily Change+5.3%
$0.017Reference Price$0.079
-202.2%ROE-54.3%
N/AProfit Margin-207.7%

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.83, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

PTX Signals

MACD momentum is picking up steam
Trading above both moving averages — the trend is your friend here
On a tear — up 11.3% over the last 5 days
Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Adequate cash runway (5 quarters)
4C filed 2026-04-29
Revenue declining (-7%)

Ask Scout AI to compare BGT and PTX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BGT vs TRU →BGT vs TTX →BIT vs BMT →BIT vs CYC →BIT vs EBR →
BGT Full Analysis → PTX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).